IRIS
PITINI, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.770
NA - Nord America 5.485
AS - Asia 2.809
SA - Sud America 1.006
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 86
OC - Oceania 6
Totale 15.299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.395
RU - Federazione Russa 2.929
SG - Singapore 1.206
BR - Brasile 874
CN - Cina 840
IE - Irlanda 711
SE - Svezia 694
UA - Ucraina 344
HK - Hong Kong 313
DE - Germania 288
GB - Regno Unito 167
IT - Italia 163
FR - Francia 153
FI - Finlandia 150
VN - Vietnam 137
IN - India 63
BD - Bangladesh 51
AR - Argentina 41
BE - Belgio 39
IQ - Iraq 30
MX - Messico 30
ZA - Sudafrica 28
CA - Canada 25
TR - Turchia 25
PL - Polonia 24
NL - Olanda 22
EC - Ecuador 21
JP - Giappone 19
CZ - Repubblica Ceca 18
VE - Venezuela 18
AT - Austria 16
CO - Colombia 16
UZ - Uzbekistan 16
KE - Kenya 13
ES - Italia 12
MA - Marocco 12
PY - Paraguay 12
AZ - Azerbaigian 11
TN - Tunisia 11
PK - Pakistan 10
CL - Cile 8
IL - Israele 8
PE - Perù 8
ID - Indonesia 7
IR - Iran 7
JM - Giamaica 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
OM - Oman 6
SA - Arabia Saudita 6
XK - ???statistics.table.value.countryCode.XK??? 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
EG - Egitto 5
JO - Giordania 5
NP - Nepal 5
PA - Panama 5
AM - Armenia 4
AU - Australia 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
NO - Norvegia 4
PS - Palestinian Territory 4
AL - Albania 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
GT - Guatemala 3
HN - Honduras 3
LB - Libano 3
LV - Lettonia 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AW - Aruba 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
Totale 15.152
Salva come PNG Salva come JPEG
Città #
Moscow 788
Ashburn 746
Dublin 711
Singapore 675
Jacksonville 653
Chandler 567
Dallas 452
Nyköping 358
Beijing 312
Hong Kong 311
San Jose 283
Council Bluffs 192
Ann Arbor 156
The Dalles 141
Princeton 123
Cambridge 119
Los Angeles 118
Des Moines 101
Lauterbourg 100
Dearborn 93
Medford 86
Boardman 70
New York 69
Lancaster 61
São Paulo 60
Woodbridge 60
Munich 59
Messina 55
Buffalo 53
Tianjin 46
Ho Chi Minh City 41
Wilmington 39
Brussels 37
Guangzhou 36
Jinan 36
Orem 32
Santa Clara 32
Hanoi 29
Redondo Beach 28
Rio de Janeiro 27
Shenyang 26
Houston 25
San Mateo 22
Seattle 22
Turku 22
Chicago 21
Warsaw 21
Columbus 20
Belo Horizonte 19
Shanghai 18
Tokyo 18
Nanjing 17
Ningbo 17
Atlanta 16
Brno 16
Denver 16
Düsseldorf 16
Haikou 16
Brasília 15
Chennai 15
Zhengzhou 15
Nanchang 14
Vienna 14
Auburn Hills 13
Frankfurt am Main 13
Stockholm 13
Taizhou 13
Tashkent 13
Baghdad 12
Brooklyn 12
Goiânia 12
Hangzhou 12
Hebei 12
Phoenix 12
Salvador 12
Amsterdam 11
Baku 11
Curitiba 11
Johannesburg 11
Quito 11
San Francisco 11
Boston 10
Campinas 10
North Bergen 10
Porto Alegre 10
Shenzhen 10
Buenos Aires 9
Dhaka 9
Hyderabad 9
Montreal 9
Nairobi 9
Ribeirão Preto 9
Barnet 8
Bologna 8
Cape Town 8
Manaus 8
Milan 8
Paris 8
Pune 8
Recife 8
Totale 8.759
Salva come PNG Salva come JPEG
Nome #
Amplification and overexpression of the PSMB5 gene contributes to bortezomib resistance in retreatment of patients with multiple myeloma. 237
Bendamustine with Rituximab Is Safe and Effective As FRONT LINE Therapy in Elderly B-CLL Patients. an ITALIAN RETROSPECTIVE MULTICENTER Experience 229
Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options 218
90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatment. 210
Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms 200
EML4-ALK fusion gene in lung adenocarcinoma: A retrospective analysis of the outcome of cisplatin plus pemetrexed treated patients. 199
An accessory spleen wrongly recognised as relapse by positron emission tomography 197
Should the Use of Surveillance Imaging in Diffuse Large B-Cell Lymphoma Be Discontinued? 195
CLINICAL ACTIVITY OF BORTEZOMIB IN RELAPSED OR REFRACTORY GASTRIC MARGINAL ZONE B-CELL LYMPHOMA OF MALT TYPE 191
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report 188
An acute-leukaemia-like picture due to breast carcinoma cells. 187
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 186
AMIFOSTINE IN CONJUCTION WITH H.D. VP16 AND G-CSF ENABLE PBSC COLLECTION IN MULTIPLE MYELOMA PATIENTS WHO FAILED CTX INDUCED MOBILIZATION 184
Emerging markers of cachexia predict survival in cancer patients. 182
Effect of treatment with amifostine in patients with myelodisplastic syndromes on clinical outcome and apoptosis in bone marrow 182
Amplification and overexpression of the PSMB5 gene contribute to Bortezomib resistance in re-treatment of patients with Multiple Myeloma 179
Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas 178
Amifostine in conjuction with G-CSF enhances chemoterapy mobilization of peripheral blood progenitor cell 178
Beta=interferon in the treatment of 14 patie nts with advanced colorectal carcinoma. J Exp Pathol. 1987 Summer;3(4):603-5. No abstract available. PMID: 3454807 [PubMed - indexed for MEDLINE] 177
Trattamento endoscopico scleroterapico nelle neoplasie sanguinanti del tratto digestivo. 176
90Y-IBRITUMOMAB TIUXETAN CONSOLIDATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL OF INTERMEDIATE/HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS NOT RESPONDING ADEQUATELY TO FIRST 172
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 169
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy. 167
Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST 166
ANCHE IN VIVO IL PAMIDRONATO E' UN INDUTTORE DELLA APOPTOSI NELLE PLASMACELLULE MIELOMATOSE 165
A sequential chemoimmunotherapy protocol can obtain a high proportion of molecular remission in chronic lymphocytic leukaemia 163
Fatal delayed diagnosis in a patient with falciparum malaria 163
Myelodysplastic syndrome/acute myelogenous leukaemia after adjuvant chemotherapy with pyrimidine anti-metabolites in three patients 160
Endobronchial electrocautery for the dehydration of lung cancer. 160
90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward? 159
AN UNUSUAL PRESENTATION OF SCHISTOSOMIASIS 156
CIRCULATING PLASMA CELLS IN MULTIPLE MYELOMA: CORRELATION WITH DISEASE STAGE 156
Association between XPD 312 single nucleotide polymorphism (SNP) and clinical outcome in stage IIIA-B non-small-cell lung cancer (NSCLC) patients (P) < 59 years (Y) treated with chemotherapy followed by surgery 156
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation 154
Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis? 151
STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma 150
Thyroid function, autoimmunity and nodules in hematological malignancies 148
IMATINIB-INDUCED APOPTOSIS IN EOSINOPHILS OF PATIENTS WITH A HYPEREOSINOPHILIC SYNDROME PREDICTS RESPONSE TO TREATMENT 147
Erlotinib therapy in a patient with non-small-cell lung cancer and brain metastases 146
Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes 146
SUBCUTANEOUS LOW-DOSE ALEMTUZUMAB AS FIRST LINE THERAPY FOR ELDERLY CLL PATIENTS WITH DELETION OF 17p 144
Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma. 144
Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide 143
Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report 141
Use of bisphosphonates in oncology 140
Temozolomide-induced shrinkage of a pituitary carcinoma. 139
Circulating plasma cells in Multiple Myeloma: correlation with disease stage 138
How cells respond to interferons. 135
ERLOTINIB IN A PATIENT WITH ACUTE MYELOGENOUS LEUKEMIA AND CONCOMITANT NON-SMALL-CELL LUNG CANCER 134
Imatinib-induced apoptosis in the eosinophils of patients with a hypereosinophilic syndrome: A surrogate marker of response? 134
DASATINIB INDUCES A RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA 133
MYELODYSPLASTIC SYNDROMES DEVELOPING DURING IMATINIB THERAPY FOR GIST 133
Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient 132
Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF 128
ADVERSE PROGNOSTIC FACTOR OF p53 GENE DELECTION DETECTED BY FISH IN MULTIPLE MYELOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION 127
ANALISI SEQUENZIALE DELLA TRISOMIA 12 NELLA LEUCEMIA LINFATICA CRONICA 125
ALTE DOSI: QUESTIONI APERTE E SVILUPPI FUTURI 124
Retrospective analysis of P-STAT6 expression as a predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate 124
Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma 123
OUR EXPERIENCE ON THE EFFECTS OF TAMOXIFEN ON BLOOD COAGULATION IN PATIENTS OPERATED FOR BREAST CANCER Folia Oncologica vol.XIV-n.2-3 (Aprile-Settembre)-1991 122
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 122
MORPHOLOGICAL, PHENOTYPIC AND KARYOTYPIC CHARACTERIZATION OF A NOVEL NATURAL-KILLER-CELL TARGET - EVIDENCE OF INVOLVEMENT OF MHC CLASS-I MOLECULES IN NK CELL RECOGNITION 121
Resistance to PGE(2) inhibition of PWM-stimulated lymphocytes from neoplastic patients 120
Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent 120
IMMUNOCHEMOTHERAPY WITH RITUXIMAB AND TEMOZOLOMIDE FOR CENTRAL NERVOUS SYSTEM LYMPHOMAS 119
Myeloid-derived suppressor cells absolute counts in predicting durable response to R-CHOP in patients with follicular lymphoma. 118
Is radiotherapy still necessary for diffuse large B-cell lymphoma therapy? 116
Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease. 116
Necrotizing fasciitis as a rare complication of osteonecrosis of the jaw in a patient with multiple myeloma treated with lenalidomide: case report and review of the literature. 110
DIABETIC FOOT DISEASE IN A PATIENT WITH MULTIPLE MYELOMA RECEIVING THALIDOMIDE 107
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease 106
Circulating Mitotic Figures In A Patient With Dual Infection By Epstein-Barr Virus And Cytomegalovirus. 105
Pitfalls of positron emission tomography for assessing relapse in Hodgkin'sdisease: a case report 104
Spontaneous rupture of spleen during peripheral blood stem cell mobilization in a patient with breast cancer 104
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study 101
null 99
GENE EXPRESSION PROFILING DOES NOT IDENTIFY MOLECULAR SUBGROUP AMONG NODAL PERIPHERAL T-CELL LYMPHOMAS 95
Sequential treatment with alemtuzumab and rituximab can induce long-term responses in splenic marginal zone lymphoma 95
SUCCESSFULL MOBILIZATION OF PERIPHERAL PROGENITOR CELLS WITH PACLITAXEL AND LENOGRASTIM PATIENTS WITH METASTATIC BREAST CANCER 93
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence 93
Salvage therapy for primary central nervous system lymphoma with Y-90-Ibritumomab and Temozolomide 92
Uso di Bortezomib come terapia di prima linea nella leucemia plasmacellulare primaria 91
null 90
PIK3CA mutations in breast cancer: A potential predictive marker 90
Bisphosphonates-associated osteonecrosis of the jaw: A long-term follow-up of a series of 35 cases observed by GISL and evaluation of its frequency over time. 90
Personalized treatment of early-stage non-small-cell lung cancer: The challenging role of EGFR inhibitors 89
RESPONSE TO IMATINIB IN CHRONIC MYELOPROLIFERATIVE DISEASES WITH ACTIVATION OF THE PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR (PDGF betaR) 88
ERYTHROPOIETIN IN CONJUNCTION WITH H.D. VP16 AND LENOGRASTIM ENABLE PBPC COLLECTION IN MULTIPLE MYELOMA PATIENTS WHO FAILED CTX INDUCED MOBILIZATION 88
LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKIN'S DISEASE 88
Single-dose of pegfilgrastim after chemotherapy is sufficient for mobilization of peripheral blood stem cells in patients with multiple myeloma 87
Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab 87
IMPIEGO DELLA AMIFOSTINE+HD VP16+G-CSF NEI PAZIENTI CON MIELOMA MULTIPLO CHE NON MOBILIZZANO DOPO CTX+G-CSF 87
THALIDOMIDE IN COMBINATION WITH DCEP OVERCOMES VAD CHEMORESISTENCE AND ALLOWS PBSC COLLECTION IN MULTIPLE MYELOMA PATIENTS 87
LIMITATIONS OF MOLECULAR DETECTION OF CK19 mRNA-POSITIVE CELLS IN THE PERIPHERAL BLOOD OF BREAST CANCER PATIENTS WITH HISTOLOGICALLY NEGATIVE AXILLARY LYMPH NODES 87
Risk of second malignant neoplasm among patients with lymphoma 87
Immunochemotherapy with temozolomide and rituximab for central nervous system lymphomas in an elderly population. 86
ERYTHROPOIETIN IN COMBINATION WITH LENOGRASTIM AFTER CYCLOPHOSPHAMIDE IMPROVES PERIPHERAL BLOOD PROGENITOR CELL YIELD IN MULTIPLE MYELOMA PATIENT 85
Retrospective analysis of P-STAT6 expression as a predictive marker in primary nervous system lymphoma patients assigned to high-dose methotrexate. 85
Efficacy and safety of bortezomib in patients with plasma cell leukemia 85
Single-dose pegfilgrastim after chemotherapy is sufficient for mobilisation of peripheral blood stem cells in patients with multiple myeloma 84
Totale 13.607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022842 0 139 18 17 25 3 58 27 5 160 154 236
2022/20232.164 173 209 102 170 187 205 23 136 855 9 71 24
2023/2024445 38 88 29 57 28 83 14 34 3 22 3 46
2024/20252.370 28 34 31 145 106 71 33 597 606 156 183 380
2025/20266.586 325 390 478 362 535 1.460 878 787 897 252 97 125
2026/2027295 109 186 0 0 0 0 0 0 0 0 0 0
Totale 15.299